Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alliqua Biomedical (ALQA)

Alliqua Biomedical (ALQA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Alliqua, Inc. is a biomedical company. The company focused on the development, manufacturing and distribution of proprietary transdermal wound care and drug delivery technologies. Its technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers. The company's product includes SilverSeal(R) a hydrogel wound dressing with silver coated fibers and Hydress(R) an over-the-counter hydrogel wound dressing. It serves the healthcare industry including wound healing, medical diagnostics and cosmeceuticals. Alliqua, Inc. is headquartered in Langhorne, Pennsylvania.
(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Sales 2,220 19,570 18,240 15,040 4,790
Sales Growth -88.66% +7.29% +21.28% +213.99% +166.11%
Net Income -8,420 -25,710 -28,240 -26,020 -25,450
Net Income Growth +67.25% +8.96% -8.53% -2.24% -15.79%
(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Total Assets 9,680 32,940 54,500 89,750 29,720
Total Assets Growth -70.61% -39.56% -39.28% +201.99% +70.32%
Total Liabilities 1,430 17,270 22,410 37,330 7,210
Total Liabilities Growth -91.72% -22.94% -39.97% +417.75% +106.00%
(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Operating Cash Flow -9,710 -10,670 -18,340 -21,620 -13,290
Operating Cash Flow Growth +9.00% +41.82% +15.17% -62.68% -178.62%
Net Cash Flow 6,700 -3,400 -20,500 9,310 4,670
Change in Net Cash Flow +297.06% +83.41% -320.19% +99.36% -60.56%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar